Fennec Pharmaceuticals Inc.
FENC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001211583
In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 5 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Fennec Pharmaceuticals Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 54 | 56 | +2 |
| Shares | 13.0M | 14.1M | +1.07M (+8.2%) |
| Value | $108.5M | $124.5M | +$16.0M (+14.8%) |
New holders (20)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 261,485 | $2.31M | 0.00% |
| Northern Trust Corp | 114,483 | $1.01M | 0.00% |
| Lion Point Capital, LP | 110,000 | $971.3K | 0.72% |
| Vanguard Group Inc | 79,873 | $705.3K | 0.00% |
| Bank of New York Mellon Corp | 45,242 | $399.5K | 0.00% |
| Charles Schwab Investment Management Inc | 41,497 | $366.4K | 0.00% |
| Nuveen Asset Management, LLC | 24,461 | $303.6K | 0.00% |
| Wexford Capital LP | 26,414 | $233.2K | 0.05% |
| Rhumbline Advisers | 19,731 | $174.2K | 0.00% |
| Eudaimonia Advisors LLC | 17,130 | $151.3K | 0.10% |
| New York State Common Retirement Fund | 10,600 | $93.6K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 10,398 | $91.8K | 0.00% |
| MetLife Investment Management | 9,679 | $85.5K | 0.00% |
| American International Group, Inc. | 8,735 | $77.1K | 0.00% |
| California State Teachers Retirement System | 6,037 | $53.3K | 0.00% |
| HighMark Wealth Management LLC | 3,000 | $26.5K | 0.02% |
| Amalgamated Bank | 2,018 | $18.0K | 0.00% |
| Legal & General Group Plc | 1,938 | $17.1K | 0.00% |
| Ameritas Investment Partners, Inc. | 1,499 | $13.2K | 0.00% |
| Metropolitan Life Insurance Co | 1,003 | $8.86K | 0.00% |
Sold out (18)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Tamarack Advisers, LP | 149,200 | $1.24M |
| 1492 Capital Management LLC | 94,839 | $789.1K |
| Jane Street Group, LLC | 88,240 | $734.2K |
| HRT Financial LP | 54,635 | $454.0K |
| AWM Investment Company, Inc. | 47,600 | $396.0K |
| Qube Research & Technologies Ltd | 40,195 | $334.4K |
| Two Sigma Advisers, LP | 34,200 | $284.5K |
| Squarepoint Ops LLC | 20,393 | $169.7K |
| Janney Montgomery Scott LLC | 20,000 | $166.0K |
| Man Group plc | – | $139.6K |
| Marshall Wace, LLP | 15,066 | $125.3K |
| Jump Financial, LLC | 14,220 | $118.3K |
| LMR Partners LLP | 11,402 | $94.9K |
| Cubist Systematic Strategies, LLC | 11,304 | $94.0K |
| Boothbay Fund Management, LLC | 10,818 | $90.0K |
| Point72 Asset Management, L.P. | 3,100 | $25.8K |
| Point72 Middle East FZE | 3,087 | $25.7K |
| Tucker Asset Management LLC | 500 | $4.16K |